Methyl Aminolevulinate

DRUG3 trials

Sponsors

Fundacion Instituto De Investigacion Sanitaria Aragon, Universidad de Antioquia, University of Sao Paulo General Hospital

Conditions

Actinic KeratosisActinic keratosesSkin Aging

Phase 2

Randomised, double-blind, multicentre clinical trial to evaluate the efficacy and safety of topical metformin in adjuvant to daylight photodynamic therapy in actinic keratoses.

Not yet recruitingCTIS2025-520798-38-00

Fundacion Instituto De Investigacion Sanitaria AragonActinic keratoses

Target: 135Updated: 2025-01-30

Phase 3

Trial of Methyl Aminolevulinate Plus Aktilite in Facial Photodamage

CompletedNCT00629317

Universidad de AntioquiaSkin Aging

Start: 2008-02-29End: 2009-03-31Updated: 2009-03-16

Unknown Phase

Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization

University of Sao Paulo General HospitalActinic Keratosis

Start: 2016-09-30End: 2017-07-31Target: 20Updated: 2017-01-06